Skip to main content
RT @AurelieRheumo: 💤cognitive behavioural therapy 2 hours/wk for 6 wks for insomnia improves RA PROs at 26 wks

Insom

Aurelie Najm AurelieRheumo

3 years 10 months ago
💤cognitive behavioural therapy 2 hours/wk for 6 wks for insomnia improves RA PROs at 26 wks Insomnia Severity Index -9.8 RAID -1.4 PGA -13 Small sample size wk6 trend improvement sleep efficiency 89% vs84% p=0.07 but not wk26 https://t.co/rpKdtbREYs Abs#2188 #ACR22 @RheumNow https://t.co/kEBcPAdIKW
RT @uptoTate: Interesting Abs 1997 finds butyrate supplementation in RA assoc'd w/changes in human gut microbiota compos

Dr. Rachel Tate uptoTate

3 years 10 months ago
Interesting Abs 1997 finds butyrate supplementation in RA assoc'd w/changes in human gut microbiota composition and in peripheral Treg abundance and markers of Treg activation. More data needed to determine clinical/dz activity relevence. #ACR22 @RheumNow https://t.co/tQocYUU0Er
RT @bella_mehta: #PregnantWoman with #sle - n = 873
Highest overall adverse events in Preexisting HTN
complicated by ra

Bella Mehta bella_mehta

3 years 10 months ago
#PregnantWoman with #sle - n = 873 Highest overall adverse events in Preexisting HTN complicated by race We have a Modifiable risk factor - HTN to work closely abst#2107 @rheumnow #ACR22 #ACRBest https://t.co/EC8c7Dzrvs https://t.co/Jydz0uo1bv
RT @AurelieRheumo: Interosseous tendon inflammation (ITI) the new predictor of clinical RA in pts w/ clinically suspect

Aurelie Najm AurelieRheumo

3 years 10 months ago
Interosseous tendon inflammation (ITI) the new predictor of clinical RA in pts w/ clinically suspect arthralgia. 600+ pts Hands MRI Present 10% pts w/ CSA, 1% symptom free 27% ACPA+ 7% ACPA- HR 4.5 dvlpmt of clinical RA https://t.co/BmRF1tLFx9 Abs#2204 #ACR22 @RheumNow https://t.co/F8DUxiI2dh
RT @ericdeinmd: Thieves Market #ACR22
Amoebic arthritis - is it rare?
Case from Indonesia
After the case, found it in 3

Eric Dein ericdeinmd

3 years 10 months ago
Thieves Market #ACR22 Amoebic arthritis - is it rare? Case from Indonesia After the case, found it in 3 other synovial fluids! Rx with surgery, metronidazole - later rx for post-ifn arthritis and gout @RheumNow https://t.co/oi8PqtTTyc
RT @bella_mehta: Severe subtype of #sJIA HLADRB1*15:01 known to be associated with adverse drug reactions to biologics.

Bella Mehta bella_mehta

3 years 10 months ago
Severe subtype of #sJIA HLADRB1*15:01 known to be associated with adverse drug reactions to biologics. prospective cohort - 65pts. - Anakinra effective irrespective of HLADRB1*15:01 - No difference in eosinophilia - Recommend not to wait to start tx @rheumnow #ACR22 abst#L12 https://t.co/LX5lMJOKRf
RT @AurelieRheumo: Alert 🚨
New imaging technology

MSOT = combination of US and photo acoustic imaging

Detects metab

Aurelie Najm AurelieRheumo

3 years 10 months ago
Alert 🚨 New imaging technology MSOT = combination of US and photo acoustic imaging Detects metabolites in enthesis and synovitis 🫱🏼>Hb and O2 saturation correlate w/ Doppler+ 🫱🏼>Hb & collagen correlate w/ calcifications https://t.co/X18fGFVh5L Abs#2205 #ACR22 @RheumNow https://t.co/84BU5YUrCz
RT @drdavidliew: RA really does still impact employment outcomes for many, despite T2T.

@earlyarthritis🇨🇦 data in

David Liew drdavidliew

3 years 10 months ago
RA really does still impact employment outcomes for many, despite T2T. @earlyarthritis🇨🇦 data in working age people show many back in the game in the first year, but not many more after that. Plenty more to do to get all our pts back to their best! ABST1967 #ACR22 @RheumNow https://t.co/isD1rgkFoH
RT @RHEUMarampa: SURPASS was a head-to-head study comparing SEC vs ADA biosimilar (SDZ-ADL) in r-axSpA on spinal radio p

sheila RHEUMarampa

3 years 10 months ago
SURPASS was a head-to-head study comparing SEC vs ADA biosimilar (SDZ-ADL) in r-axSpA on spinal radio progression: Results showed no significant diff in spinal radio progression bet. the 2 grps. Biosimilars remain tx options for r-axSpA. #ACR22 @RheumNow ABST#L15
RT @JulianSegan: Foot involvement in RA not included in disease activity scores. This abstract showed that patients w/ a

Julian Segan JulianSegan

3 years 10 months ago
Foot involvement in RA not included in disease activity scores. This abstract showed that patients w/ active foot involvement have higher scores anyway (driven by physician & patient global) but examining feet would have only changed management in 3.1%. @RheumNow ABST0265 #ACR22 https://t.co/ckuB8R4ZTF
RT @DrTrishHarkins: Response to ULT
in
Hyperuricaemia +non episodic foot pain not meeting c

Patricia Harkins DrTrishHarkins

3 years 10 months ago
Response to ULT in Hyperuricaemia +non episodic foot pain not meeting criteria for gout classification predicted by 🔥US findings of 👉double contour sign 👉tophus Abst 1828 #ACR22 @FloodRachael @RheumNow https://t.co/ATzEgFOWU0
RT @uptoTate: PNEUMOVAS study results suggest AAV pts on RTX showed improved S. Pneumoniae ab response with double dose

Dr. Rachel Tate uptoTate

3 years 10 months ago
PNEUMOVAS study results suggest AAV pts on RTX showed improved S. Pneumoniae ab response with double dose of PCV13 at day 0 and day 7 followed by a single dose of PPV23 at M5. More data needed on this updated, clinical strategy. Abs L16 #ACR22 @RheumNow https://t.co/m71VQMGZ68
Polymyalgia rheumatica: more than just steroids at #ACR22

After decades of having little else proven apart from glucoc

Dr. John Cush RheumNow

3 years 10 months ago
Polymyalgia rheumatica: more than just steroids at #ACR22 After decades of having little else proven apart from glucocorticosteroids with which to treat PMR, evidence for steroid-sparing options has grown in recent years. https://t.co/CjMzEqRan8 https://t.co/5UixhVemqY
RT @drdavidliew: SMS/email reminders slightly improve fluvax uptake in RA pts
(nested RCT within ART registry, France)
A

David Liew drdavidliew

3 years 10 months ago
SMS/email reminders slightly improve fluvax uptake in RA pts (nested RCT within ART registry, France) ABST2002 #ACR22 @RheumNow @philipcrobinson & I wrote @TheLancetRheum on how to improve preventative med https://t.co/55j8rdv3nV I think we need multiple simultaneous strategies! https://t.co/pNfpWLVkac
RT @KDAO2011: Big change for #SLE Trials coming soon.
My exclusive interview w/Prof @EricFMorand. Future trials will li

TheDaoIndex KDAO2011

3 years 10 months ago
Big change for #SLE Trials coming soon. My exclusive interview w/Prof @EricFMorand. Future trials will likely incorporate this Novel Treatment Response Measurement (TRM) Tool #ACR22 @rheumnow https://t.co/TXsxJi3qhC
×